Vol 24, No 3 (2017)
Editorial
Published online: 2017-04-18

open access

Page views 3533
Article views/downloads 2966
Get Citation

Connect on Social Media

Connect on Social Media

DECISION-CTO: A “negative” clinical trial? Really?

Juan Luis Gutiérrez-Chico1, Yves Louvard2
Pubmed: 28417448
Cardiol J 2017;24(3):231-233.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Mehran R, Claessen B, Godino C, et al. Long-Term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc Interv. 2011; 4(9): 952–961.
  2. Claessen BE, Dangas GD, Weisz G, et al. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. Eur Heart J. 2012; 33(6): 768–775.
  3. Rosner GF, Kirtane AJ, Genereux P, et al. Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Circulation. 2012; 125(21): 2613–2620.
  4. George S, Cockburn J, Clayton T, et al. Long-Term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database. J Am Coll Cardiol. 2014; 64(3): 235–243.
  5. Ladwiniec A, Allgar V, Thackray S, et al. Medical therapy, percutaneous coronary intervention and prognosis in patients with chronic total occlusions. Heart. 2015; 101(23): 1907–1914.
  6. Farooq V, Serruys PW, Garcia-Garcia HM, et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol. 2013; 61(3): 282–294.